Spotlight on the new ACC/AHA lipid and JNC8 hypertension guidelines, EGFR inhibitors vs chemotherapy for NSCLC, and more.
Apr 8, 2014
09:33
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Editor's Audio Summary by Phil B. Fontanarosa, MD, MBA, Executive Editor, the Journal of the American Medical Association, for the April 09, 2014 issue
JAMA Editors' Summary